TORMEIKA SANFORD: Open Payments
NPI 1356679310 · CAMBRIDGE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 12 payments from 8 companies in 2025. Trend: 2023 $331 · 2024 $147 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $76 |
| Amgen Inc. | 3 | $49 |
| SANOFI-AVENTIS U.S. LLC | 1 | $29 |
| Lilly USA, LLC | 1 | $25 |
| Exact Sciences Corporation | 1 | $21 |
| PFIZER INC. | 1 | $18 |
| Dynavax Technologies Corporation | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: Ozempic, OTEZLA, TZIELD, MOUNJARO, Wegovy, Cologuard Collection Kit, PREVNAR 20, Heplisav-B.
Industry payments across MD — which companies pay providers there.
